These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 7891847
21. Presence and characterization of the serotonin transporter in human resting lymphocytes. Marazziti D, Rossi A, Giannaccini G, Baroni S, Lucacchini A, Cassano GB. Neuropsychopharmacology; 1998 Aug; 19(2):154-9. PubMed ID: 9629569 [Abstract] [Full Text] [Related]
22. Solubilization and assay of [3H]imipramine binding sites from human platelets. Davis A, Morris J, Tang SW. Eur J Pharmacol; 1983 Jan 21; 86(3-4):353-9. PubMed ID: 6299755 [Abstract] [Full Text] [Related]
23. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification. D'Hondt P, Maes M, Leysen JE, Gommeren W, Scharpé S, Cosyns P. J Affect Disord; 1994 Sep 21; 32(1):27-35. PubMed ID: 7798464 [Abstract] [Full Text] [Related]
25. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin. Gulati A, Arora RC, Crayton J. Eur J Pharmacol; 1993 Feb 09; 231(2):151-6. PubMed ID: 8453971 [Abstract] [Full Text] [Related]
26. Role of essential sulfhydryl groups in drug interactions at the neuronal 5-HT transporter. Differences between amphetamines and 5-HT uptake inhibitors. Wolf WA, Kuhn DM. J Biol Chem; 1992 Oct 15; 267(29):20820-5. PubMed ID: 1400397 [Abstract] [Full Text] [Related]
29. Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres. Rosel P, Arranz B, Urretavizcaya M, Oros M, San L, Vallejo J, Navarro MA. Psychiatry Res; 2002 Aug 30; 111(2-3):105-15. PubMed ID: 12374628 [Abstract] [Full Text] [Related]
30. Two affinity states for [3H]imipramine binding to the human platelet 5-hydroxytryptamine carrier: an explanation for the allosteric interaction between 5-hydroxytryptamine and imipramine. O'Riordan C, Phillips OM, Williams DC. J Neurochem; 1990 Apr 30; 54(4):1275-80. PubMed ID: 2313287 [Abstract] [Full Text] [Related]
34. Inhibition of MAO activity, 3H-imipramine binding, 3H-paroxetine binding and 3H-5-HT uptake by human cerebrospinal fluid. Egashira T, Goto S, Murayama F, Yamanaka Y. J Neural Transm Suppl; 1990 Apr 30; 32():447-56. PubMed ID: 2150970 [Abstract] [Full Text] [Related]
35. Interaction of lectins with human platelet serotonin transporter. Helmeste DM, Chudzik J, Tang SW. Eur J Pharmacol; 1994 Feb 15; 266(3):327-31. PubMed ID: 8174615 [Abstract] [Full Text] [Related]
36. One-step purification of the serotonin transporter located at the human platelet plasma membrane. Launay JM, Geoffroy C, Mutel V, Buckle M, Cesura A, Alouf JE, Da Prada M. J Biol Chem; 1992 Jun 05; 267(16):11344-51. PubMed ID: 1534559 [Abstract] [Full Text] [Related]
37. [3H]citalopram binding to brain and platelet membranes of human and rat. Plenge P, Mellerup ET. J Neurochem; 1991 Jan 05; 56(1):248-52. PubMed ID: 1824783 [Abstract] [Full Text] [Related]
38. Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine. Naylor L, Dean B, Opeskin K, Pavey G, Hill C, Keks N, Copolov D. J Neural Transm (Vienna); 1996 Jan 05; 103(6):749-57. PubMed ID: 8836936 [Abstract] [Full Text] [Related]
39. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers. Spigset O, Allard P, Mjörndal T. Biol Psychiatry; 1998 May 15; 43(10):774-80. PubMed ID: 9606533 [Abstract] [Full Text] [Related]
40. Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients. Marazziti D, Rossi A, Gemignani A, Giannaccini G, Pfanner C, Milanfranchi A, Presta S, Lucacchini A, Cassano GB. Neuropsychobiology; 1996 May 15; 34(4):184-7. PubMed ID: 9121618 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]